PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-42.27%
Negative net income growth while 1113.HK stands at 18.80%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.22%
Some D&A expansion while 1113.HK is negative at -3.83%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-814.38%
Negative yoy deferred tax while 1113.HK stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-703.50%
Negative yoy SBC while 1113.HK is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-154.56%
Negative yoy working capital usage while 1113.HK is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
100.00%
AR growth of 100.00% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
100.00%
Inventory growth of 100.00% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-100.00%
Negative yoy AP while 1113.HK is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-921.71%
Negative yoy usage while 1113.HK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-13.18%
Both negative yoy, with 1113.HK at -42.42%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-63.88%
Both yoy CFO lines are negative, with 1113.HK at -153.77%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
22.53%
Lower CapEx growth vs. 1113.HK's 100.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-95.98%
Both yoy lines negative, with 1113.HK at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-142.48%
Negative yoy purchasing while 1113.HK stands at 81.81%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-51.78%
Both yoy lines are negative, with 1113.HK at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
14.39%
Less 'other investing' outflow yoy vs. 1113.HK's 154.71%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-60.55%
Both yoy lines negative, with 1113.HK at -18.30%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-38.36%
Negative yoy issuance while 1113.HK is 100.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.